Summary: Donation of CCP, Blood Components and HCT/Ps, Including Information on COVID-19 Vaccines or Treatment with CCP or Monoclonals (updated 04/14/21)
This section contains information on questionnaires used to screen prospective donors and help ensure the safety of the donation process as well as the product being donated. AABB has played a leadership role in the development of model questionnaires for blood collection facilities as well as for facilities involved in the collection of hematopoietic progenitor cells (HPCs).
The Netherlands Will Introduce Individual Donor Assessment in 2024
March 20, 2023
AABB, Canadian Blood Services Announce Partnership to Help US Blood Collectors Prepare for Individual Risk Assessment
February 13, 2023
REGULATORY UPDATE: AABB Publishes Analysis and Comparison of January 2023 Draft HIV Guidance, August 2020 HIV Guidance
February 08, 2023